This case series describes the aggregate rate of recovery in five consecutive subjects (six
eyes) with retinal vein occlusion (RVO) who received l-methylfolate and other vitamins via …

OBJECTIVE: To report on the occurrence of methylenetetrahydrofolate reductase (MTHFR)
deficiency in patients with retinal vein occlusion (RVO). DESIGN: Prospective case series …

PURPOSE: Thromboembolic phenomenon is one of the causes of retinal vein occlusion
(RVO) which is in fact a multifactorial disease. Therefore, we aimed to study …

purpose. The aim of this case–control study was to investigate the relationship between
homocysteine (tHcy), 5, 10 methylene tetrahydrofolate reductase (MTHFR) C677T genotype …

AIMS To determine whether plasma homocysteine, methylene tetrahydrofolate reductase
(MTHFR) C677T and factor II G20210A polymorphisms, factor VIII, and vWF are risk factors …

Background: To assess the prevalence of thrombophilia in patients with central (CRVO) and
branch retinal vein occlusion (BRVO). Methods: In 139 patients with CRVO (n= 88) and …

The role of polymorphisms of methylenetetrahydrofolate reductase (MTHFR) gene in retinal
vein occlusion (RVO) is a theme of discussion since the first reports of RVO in patients with …

Purpose: This case report describes a central retinal vein occlusion in a healthy 12-year-old
girl who developed retinal neovascularization at 24 years of age. To the knowledge of the …

Purpose To evaluate the association between serum vitamin B12/folate and retinal vein
occlusion (RVO). Methods A comprehensive search of the PubMed database was …

The role of two polymorphisms C677T and A1298C of the methylenetetrahydrofolate
reductase (MTHFR) gene in the etiology of retinal vein occlusion (RVO) has not been …